10-K Filing

SURGERY PARTNERS, INC. CIK: 1638833 FY 2021

Filing Information

Form Type	10-K
Accession Number	`0001638833-22-000019`
Period End Date	20211231
Filing Date	20220301
Fiscal Year	2021
Fiscal Period	FY
XBRL Instance	sgry-20211231_htm.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 99 Income Statement 96 Cash Flow Statement 116 Stockholders Equity 34 Comprehensive Income 15

Balance Sheet 99 line items

Line Item	Tag	Value	Unit	Period
Redeemable preferred stock, shares authorized (shares)	`TemporaryEquitySharesAuthorized`	310,000.00	shares	Point-in-time
Redeemable preferred stock, shares authorized (shares)	`TemporaryEquitySharesAuthorized`	310,000.00	shares	Point-in-time
Redeemable preferred stock, shares issued (shares)	`TemporaryEquitySharesIssued`	0.00	shares	Point-in-time
Redeemable preferred stock, shares issued (shares)	`TemporaryEquitySharesIssued`	310,000.00	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$317.90M	USD	Point-in-time
Redeemable preferred stock, shares outstanding (shares)	`TemporaryEquitySharesOutstanding`	310,000.00	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$389.90M	USD	Point-in-time
Redeemable preferred stock, shares outstanding (shares)	`TemporaryEquitySharesOutstanding`	0.00	shares	Point-in-time
Accounts receivable	`AccountsReceivableNetCurrent`	$382.20M	USD	Point-in-time
Accounts receivable	`AccountsReceivableNetCurrent`	$430.20M	USD	Point-in-time
Redeemable preferred stock, redemption value	`RedeemableNoncontrollingInterestEquityPreferredRedemptionValue`	$434.50M	USD	Point-in-time
Redeemable preferred stock, redemption value	`RedeemableNoncontrollingInterestEquityPreferredRedemptionValue`	-	USD	Point-in-time
Preferred stock, par value (in USD per share)	`PreferredStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Inventories	`InventoryNet`	$61.10M	USD	Point-in-time
Inventories	`InventoryNet`	$56.40M	USD	Point-in-time
Preferred stock, par value (in USD per share)	`PreferredStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Preferred stock, shares authorized (shares)	`PreferredStockSharesAuthorized`	20.00M	shares	Point-in-time
Preferred stock, shares authorized (shares)	`PreferredStockSharesAuthorized`	20.00M	shares	Point-in-time
Prepaid expenses	`PrepaidExpenseCurrent`	$17.60M	USD	Point-in-time
Prepaid expenses	`PrepaidExpenseCurrent`	$25.60M	USD	Point-in-time
Other current assets	`OtherAssetsCurrent`	$39.30M	USD	Point-in-time
Preferred stock, shares issued (shares)	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Other current assets	`OtherAssetsCurrent`	$27.40M	USD	Point-in-time
Preferred stock, shares issued (shares)	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Preferred stock, shares outstanding (shares)	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Total current assets	`AssetsCurrent`	$801.50M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$946.10M	USD	Point-in-time
Preferred stock, shares outstanding (shares)	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization`	$629.70M	USD	Point-in-time
Common stock, par value (in USD per share)	`CommonStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Common stock, par value (in USD per share)	`CommonStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Common stock, par value (in USD per share)	`CommonStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Common stock, par value (in USD per share)	`CommonStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization`	$544.60M	USD	Point-in-time
Intangible assets, net	`IntangibleAssetsNetExcludingGoodwill`	$43.70M	USD	Point-in-time
Common stock, shares authorized (shares)	`CommonStockSharesAuthorized`	300.00M	shares	Point-in-time
Common stock, shares authorized (shares)	`CommonStockSharesAuthorized`	300.00M	shares	Point-in-time
Intangible assets, net	`IntangibleAssetsNetExcludingGoodwill`	$46.90M	USD	Point-in-time
Common stock, shares issued (shares)	`CommonStockSharesIssued`	50.46M	shares	Point-in-time
Goodwill	`Goodwill`	$3.91B	USD	Point-in-time
Goodwill	`Goodwill`	$3.40B	USD	Point-in-time
Goodwill	`Goodwill`	$3.47B	USD	Point-in-time
Common stock, shares issued (shares)	`CommonStockSharesIssued`	89.33M	shares	Point-in-time
Investments in and advances to affiliates	`InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures`	$90.30M	USD	Point-in-time
Common stock, shares outstanding (shares)	`CommonStockSharesOutstanding`	50.46M	shares	Point-in-time
Common stock, shares outstanding (shares)	`CommonStockSharesOutstanding`	89.33M	shares	Point-in-time
Investments in and advances to affiliates	`InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures`	$88.70M	USD	Point-in-time
Right-of-use operating lease assets	`OperatingLeaseRightOfUseAsset`	$310.10M	USD	Point-in-time
Right-of-use operating lease assets	`OperatingLeaseRightOfUseAsset`	$324.10M	USD	Point-in-time
Long-term deferred tax assets	`DeferredIncomeTaxAssetsNet`	$114.40M	USD	Point-in-time
Long-term deferred tax assets	`DeferredIncomeTaxAssetsNet`	$124.80M	USD	Point-in-time
Other long-term assets	`OtherAssetsNoncurrent`	$59.10M	USD	Point-in-time
Other long-term assets	`OtherAssetsNoncurrent`	$27.00M	USD	Point-in-time
Total assets	`Assets`	$6.12B	USD	Point-in-time
Total assets	`Assets`	$5.41B	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$124.90M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$100.20M	USD	Point-in-time
Accrued payroll and benefits	`EmployeeRelatedLiabilitiesCurrent`	$77.10M	USD	Point-in-time
Accrued payroll and benefits	`EmployeeRelatedLiabilitiesCurrent`	$65.40M	USD	Point-in-time
Medicare accelerated payments and deferred governmental grants	`MedicareAcceleratedPaymentsAndDeferredGovernmentalGrantsCurrent`	$109.80M	USD	Point-in-time
Medicare accelerated payments and deferred governmental grants	`MedicareAcceleratedPaymentsAndDeferredGovernmentalGrantsCurrent`	$64.40M	USD	Point-in-time
Other current liabilities	`OtherLiabilitiesCurrent`	$210.00M	USD	Point-in-time
Other current liabilities	`OtherLiabilitiesCurrent`	$217.00M	USD	Point-in-time
Current maturities of long-term debt	`LongTermDebtAndCapitalLeaseObligationsCurrent`	$60.40M	USD	Point-in-time
Current maturities of long-term debt	`LongTermDebtAndCapitalLeaseObligationsCurrent`	$64.40M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$556.80M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$536.80M	USD	Point-in-time
Long-term debt, less current maturities	`LongTermDebtAndCapitalLeaseObligations`	$2.79B	USD	Point-in-time
Long-term debt, less current maturities	`LongTermDebtAndCapitalLeaseObligations`	$2.88B	USD	Point-in-time
Right-of-use operating lease liabilities	`OperatingLeaseLiabilityNoncurrent`	$315.60M	USD	Point-in-time
Right-of-use operating lease liabilities	`OperatingLeaseLiabilityNoncurrent`	$300.90M	USD	Point-in-time
Other long-term liabilities	`OtherLiabilitiesNoncurrent`	$139.70M	USD	Point-in-time
Other long-term liabilities	`OtherLiabilitiesNoncurrent`	$87.00M	USD	Point-in-time
Non-controlling interestsredeemable	`RedeemableNoncontrollingInterestEquityCarryingAmount`	$321.00M	USD	Point-in-time
Non-controlling interestsredeemable	`RedeemableNoncontrollingInterestEquityCarryingAmount`	$330.20M	USD	Point-in-time
Non-controlling interestsredeemable	`RedeemableNoncontrollingInterestEquityCarryingAmount`	$306.80M	USD	Point-in-time
Redeemable preferred stock - Series A; shares authorized - 310,000; shares issued or outstanding - none and 310,000, respectively; redemption value - none and $434.5, respectively	`TemporaryEquityCarryingAmountAttributableToParent`	-	USD	Point-in-time
Redeemable preferred stock - Series A; shares authorized - 310,000; shares issued or outstanding - none and 310,000, respectively; redemption value - none and $434.5, respectively	`TemporaryEquityCarryingAmountAttributableToParent`	$395.00M	USD	Point-in-time
Redeemable preferred stock - Series A; shares authorized - 310,000; shares issued or outstanding - none and 310,000, respectively; redemption value - none and $434.5, respectively	`TemporaryEquityCarryingAmountAttributableToParent`	$434.50M	USD	Point-in-time
Preferred stock, $0.01 par value; shares authorized - 20,000,000; shares issued or outstanding - none	`PreferredStockValue`	-	USD	Point-in-time
Preferred stock, $0.01 par value; shares authorized - 20,000,000; shares issued or outstanding - none	`PreferredStockValue`	-	USD	Point-in-time
Common stock, $0.01 par value; shares authorized - 300,000,000; shares issued and outstanding - 89,332,557 and 50,461,706, respectively	`CommonStockValueOutstanding`	$900.00K	USD	Point-in-time
Common stock, $0.01 par value; shares authorized - 300,000,000; shares issued and outstanding - 89,332,557 and 50,461,706, respectively	`CommonStockValueOutstanding`	$500.00K	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$1.62B	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$607.90M	USD	Point-in-time
Accumulated other comprehensive loss	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-61.00M	USD	Point-in-time
Accumulated other comprehensive loss	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-31.50M	USD	Point-in-time
Retained deficit	`RetainedEarningsAccumulatedDeficit`	$-502.70M	USD	Point-in-time
Retained deficit	`RetainedEarningsAccumulatedDeficit`	$-431.80M	USD	Point-in-time
Total Surgery Partners, Inc. stockholders' equity	`StockholdersEquity`	$115.60M	USD	Point-in-time
Total Surgery Partners, Inc. stockholders' equity	`StockholdersEquity`	$1.09B	USD	Point-in-time
Non-controlling interestsnon-redeemable	`MinorityInterest`	$766.50M	USD	Point-in-time
Non-controlling interestsnon-redeemable	`MinorityInterest`	$880.60M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$882.10M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$983.40M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$1.97B	USD	Point-in-time
Total stockholders' equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$1.10B	USD	Point-in-time
Total liabilities and stockholders' equity	`LiabilitiesAndStockholdersEquity`	$5.41B	USD	Point-in-time
Total liabilities and stockholders' equity	`LiabilitiesAndStockholdersEquity`	$6.12B	USD	Point-in-time

Income Statement 96 line items

Line Item	Tag	Value	Unit	Period
Revenues	`RevenueFromContractWithCustomerIncludingAssessedTax`	$2.23B	USD	Annual
Revenues	`RevenueFromContractWithCustomerIncludingAssessedTax`	$1.86B	USD	Annual
Revenues	`RevenueFromContractWithCustomerIncludingAssessedTax`	$1.83B	USD	Annual
Salaries and benefits	`LaborAndRelatedExpense`	$550.30M	USD	Annual
Salaries and benefits	`LaborAndRelatedExpense`	$644.30M	USD	Annual
Salaries and benefits	`LaborAndRelatedExpense`	$550.00M	USD	Annual
Supplies	`SuppliesExpense`	$507.90M	USD	Annual
Supplies	`SuppliesExpense`	$538.40M	USD	Annual
Supplies	`SuppliesExpense`	$636.40M	USD	Annual
Professional and medical fees	`ProfessionalFees`	$191.40M	USD	Annual
Professional and medical fees	`ProfessionalFees`	$230.00M	USD	Annual
Professional and medical fees	`ProfessionalFees`	$154.80M	USD	Annual
Lease expense	`OperatingAndFinanceLeaseExpense`	$85.60M	USD	Annual
Lease expense	`OperatingAndFinanceLeaseExpense`	$87.40M	USD	Annual
Lease expense	`OperatingAndFinanceLeaseExpense`	$90.60M	USD	Annual
Other operating expenses	`OtherCostAndExpenseOperating`	$109.30M	USD	Annual
Other operating expenses	`OtherCostAndExpenseOperating`	$112.80M	USD	Annual
Other operating expenses	`OtherCostAndExpenseOperating`	$132.40M	USD	Annual
Cost of revenues	`OperatingCostsAndExpenses`	$1.48B	USD	Annual
Cost of revenues	`OperatingCostsAndExpenses`	$1.73B	USD	Annual
Cost of revenues	`OperatingCostsAndExpenses`	$1.41B	USD	Annual
General and administrative expenses	`GeneralAndAdministrativeExpense`	$104.00M	USD	Annual
General and administrative expenses	`GeneralAndAdministrativeExpense`	$88.60M	USD	Annual
General and administrative expenses	`GeneralAndAdministrativeExpense`	$97.10M	USD	Annual
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$76.50M	USD	Annual
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$98.80M	USD	Annual
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$94.80M	USD	Annual
Income from equity investments	`IncomeLossFromEquityMethodInvestments`	$10.80M	USD	Annual
Income from equity investments	`IncomeLossFromEquityMethodInvestments`	$10.20M	USD	Annual
Income from equity investments	`IncomeLossFromEquityMethodInvestments`	$11.30M	USD	Annual
Loss (gain) on disposals, net	`GainLossOnDispositionOfAssetsAndDeconsolidation`	$-5.70M	USD	Annual
Loss (gain) on disposals, net	`GainLossOnDispositionOfAssetsAndDeconsolidation`	$-2.20M	USD	Annual
Loss (gain) on disposals, net	`GainLossOnDispositionOfAssetsAndDeconsolidation`	$4.40M	USD	Annual
Transaction and integration costs	`BusinessCombinationIntegrationRelatedCosts`	$19.00M	USD	Annual
Transaction and integration costs	`BusinessCombinationIntegrationRelatedCosts`	$39.80M	USD	Annual
Transaction and integration costs	`BusinessCombinationIntegrationRelatedCosts`	$23.20M	USD	Annual
Impairment charges	`AssetImpairmentCharges`	-	USD	Annual
Impairment charges	`AssetImpairmentCharges`	$7.90M	USD	Annual
Impairment charges	`AssetImpairmentCharges`	$33.50M	USD	Annual
Grant funds	`GrantRevenue`	-	USD	Annual
Grant funds	`GrantRevenue`	$37.90M	USD	Annual
Grant funds	`GrantRevenue`	$46.20M	USD	Annual
Loss on debt extinguishment	`GainsLossesOnExtinguishmentOfDebt`	$-9.10M	USD	Annual
Loss on debt extinguishment	`GainsLossesOnExtinguishmentOfDebt`	$-11.70M	USD	Annual
Loss on debt extinguishment	`GainsLossesOnExtinguishmentOfDebt`	-	USD	Annual
Litigation settlement	`GainLossRelatedToLitigationSettlement`	-	USD	Annual
Litigation settlement	`GainLossRelatedToLitigationSettlement`	$-1.20M	USD	Annual
Litigation settlement	`GainLossRelatedToLitigationSettlement`	$-200.00K	USD	Annual
Other income	`OtherNonrecurringIncomeExpense`	$-1.70M	USD	Annual
Other income	`OtherNonrecurringIncomeExpense`	$-1.40M	USD	Annual
Other income	`OtherNonrecurringIncomeExpense`	$-15.50M	USD	Annual
Total operating expenses	`OperatingExpenses`	$1.92B	USD	Annual
Total operating expenses	`OperatingExpenses`	$1.68B	USD	Annual
Total operating expenses	`OperatingExpenses`	$1.60B	USD	Annual
Operating income	`OperatingIncomeLoss`	$235.90M	USD	Annual
Operating income	`OperatingIncomeLoss`	$183.00M	USD	Annual
Operating income	`OperatingIncomeLoss`	$302.20M	USD	Annual
Tax receivable agreement expense	`OtherTaxExpenseBenefit`	-	USD	Annual
Tax receivable agreement expense	`OtherTaxExpenseBenefit`	-	USD	Annual
Tax receivable agreement expense	`OtherTaxExpenseBenefit`	$2.40M	USD	Annual
Interest expense, net	`InterestIncomeExpenseNonoperatingNet`	$-221.00M	USD	Annual
Interest expense, net	`InterestIncomeExpenseNonoperatingNet`	$-201.80M	USD	Annual
Interest expense, net	`InterestIncomeExpenseNonoperatingNet`	$-178.90M	USD	Annual
Income (loss) before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic`	$81.20M	USD	Annual
Income (loss) before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic`	$54.60M	USD	Annual
Income (loss) before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic`	$-18.80M	USD	Annual
Income tax expense (benefit)	`IncomeTaxExpenseBenefit`	$9.50M	USD	Annual
Income tax expense (benefit)	`IncomeTaxExpenseBenefit`	$10.50M	USD	Annual
Income tax expense (benefit)	`IncomeTaxExpenseBenefit`	$-20.10M	USD	Annual
Net income	`ProfitLoss`	$1.30M	USD	Annual
Net income	`ProfitLoss`	$45.10M	USD	Annual
Net income	`ProfitLoss`	$70.70M	USD	Annual
Less: Net income attributable to non-controlling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	$119.90M	USD	Annual
Less: Net income attributable to non-controlling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	$141.60M	USD	Annual
Less: Net income attributable to non-controlling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	$117.40M	USD	Annual
Net loss attributable to Surgery Partners, Inc.	`NetIncomeLoss`	$-74.80M	USD	Annual
Net loss attributable to Surgery Partners, Inc.	`NetIncomeLoss`	$-70.90M	USD	Annual
Net loss attributable to Surgery Partners, Inc.	`NetIncomeLoss`	$-116.10M	USD	Annual
Less: Amounts attributable to participating securities	`UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic`	$10.30M	USD	Annual
Less: Amounts attributable to participating securities	`UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic`	$39.50M	USD	Annual
Less: Amounts attributable to participating securities	`UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic`	$35.70M	USD	Annual
Net loss attributable to common stockholders	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-155.60M	USD	Annual
Net loss attributable to common stockholders	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-81.20M	USD	Annual
Net loss attributable to common stockholders	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-110.50M	USD	Annual
Net loss per share attributable to common stockholders - basic (in USD per share)	`EarningsPerShareBasic`	$-1.12	USD	Annual
Net loss per share attributable to common stockholders - basic (in USD per share)	`EarningsPerShareBasic`	$-2.29	USD	Annual
Net loss per share attributable to common stockholders - basic (in USD per share)	`EarningsPerShareBasic`	$-3.19	USD	Annual
Net loss per share attributable to common stockholders - diluted (in USD per share)	`EarningsPerShareDiluted`	$-1.12	USD	Annual
Net loss per share attributable to common stockholders - diluted (in USD per share)	`EarningsPerShareDiluted`	$-2.29	USD	Annual
Net loss per share attributable to common stockholders - diluted (in USD per share)	`EarningsPerShareDiluted`	$-3.19	USD	Annual
Weighted average shares outstanding - basic (shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	72.43M	shares	Annual
Weighted average shares outstanding - basic (shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	48.28M	shares	Annual
Weighted average shares outstanding - basic (shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	48.78M	shares	Annual
Weighted average shares outstanding - diluted (shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	48.28M	shares	Annual
Weighted average shares outstanding - diluted (shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	48.78M	shares	Annual
Weighted average shares outstanding - diluted (shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	72.43M	shares	Annual

Cash Flow Statement 116 line items

Line Item	Tag	Value	Unit	Period
Net income	`ProfitLoss`	$1.30M	USD	Annual
Net income	`ProfitLoss`	$45.10M	USD	Annual
Net income	`ProfitLoss`	$70.70M	USD	Annual
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$76.50M	USD	Annual
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$98.80M	USD	Annual
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$94.80M	USD	Annual
Non-cash interest expense, net	`NoncashInterestIncomeExpenseNet`	$-2.50M	USD	Annual
Non-cash interest expense, net	`NoncashInterestIncomeExpenseNet`	$-4.50M	USD	Annual
Non-cash interest expense, net	`NoncashInterestIncomeExpenseNet`	$-22.00M	USD	Annual
Equity-based compensation expense	`ShareBasedCompensation`	$10.20M	USD	Annual
Equity-based compensation expense	`ShareBasedCompensation`	$17.40M	USD	Annual
Equity-based compensation expense	`ShareBasedCompensation`	$13.20M	USD	Annual
Loss (gain) on disposals, net	`GainLossOnDispositionOfAssetsAndDeconsolidation`	$-5.70M	USD	Annual
Loss (gain) on disposals, net	`GainLossOnDispositionOfAssetsAndDeconsolidation`	$-2.20M	USD	Annual
Loss (gain) on disposals, net	`GainLossOnDispositionOfAssetsAndDeconsolidation`	$4.40M	USD	Annual
Impairment charges	`AssetImpairmentCharges`	-	USD	Annual
Impairment charges	`AssetImpairmentCharges`	$7.90M	USD	Annual
Impairment charges	`AssetImpairmentCharges`	$33.50M	USD	Annual
Loss on debt extinguishment	`GainsLossesOnExtinguishmentOfDebt`	$-9.10M	USD	Annual
Loss on debt extinguishment	`GainsLossesOnExtinguishmentOfDebt`	$-11.70M	USD	Annual
Loss on debt extinguishment	`GainsLossesOnExtinguishmentOfDebt`	-	USD	Annual
Deferred income taxes	`DeferredIncomeTaxExpenseBenefit`	$-21.90M	USD	Annual
Deferred income taxes	`DeferredIncomeTaxExpenseBenefit`	$8.90M	USD	Annual
Deferred income taxes	`DeferredIncomeTaxExpenseBenefit`	$8.50M	USD	Annual
Income from equity investments, net of distributions received	`IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions`	$-500.00K	USD	Annual
Income from equity investments, net of distributions received	`IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions`	$-200.00K	USD	Annual
Income from equity investments, net of distributions received	`IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions`	$-300.00K	USD	Annual
Non-cash lease expense	`OperatingLeaseExpense`	$39.10M	USD	Annual
Non-cash lease expense	`OperatingLeaseExpense`	$40.00M	USD	Annual
Non-cash lease expense	`OperatingLeaseExpense`	$39.40M	USD	Annual
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$46.60M	USD	Annual
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$32.10M	USD	Annual
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$23.50M	USD	Annual
Medicare accelerated payments and deferred governmental grants	`IncreaseDecreaseInMedicareAcceleratedPaymentsAndDeferredGovernmentalGrants`	$-73.60M	USD	Annual
Medicare accelerated payments and deferred governmental grants	`IncreaseDecreaseInMedicareAcceleratedPaymentsAndDeferredGovernmentalGrants`	$135.20M	USD	Annual
Medicare accelerated payments and deferred governmental grants	`IncreaseDecreaseInMedicareAcceleratedPaymentsAndDeferredGovernmentalGrants`	-	USD	Annual
DOJ settlement payments	`IncreaseDecreaseInSettlementPayments`	-	USD	Annual
DOJ settlement payments	`IncreaseDecreaseInSettlementPayments`	$4.00M	USD	Annual
DOJ settlement payments	`IncreaseDecreaseInSettlementPayments`	$32.20M	USD	Annual
Other operating assets and liabilities	`IncreaseDecreaseInOtherOperatingCapitalNet`	$45.30M	USD	Annual
Other operating assets and liabilities	`IncreaseDecreaseInOtherOperatingCapitalNet`	$8.70M	USD	Annual
Other operating assets and liabilities	`IncreaseDecreaseInOtherOperatingCapitalNet`	$43.40M	USD	Annual
Net cash provided by operating activities	`NetCashProvidedByUsedInOperatingActivities`	$129.50M	USD	Annual
Net cash provided by operating activities	`NetCashProvidedByUsedInOperatingActivities`	$246.90M	USD	Annual
Net cash provided by operating activities	`NetCashProvidedByUsedInOperatingActivities`	$87.10M	USD	Annual
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$73.60M	USD	Annual
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$57.60M	USD	Annual
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$42.90M	USD	Annual
Payments for acquisitions, net of cash acquired	`PaymentsToAcquireBusinessesNetOfCashAcquired`	$13.80M	USD	Annual
Payments for acquisitions, net of cash acquired	`PaymentsToAcquireBusinessesNetOfCashAcquired`	$285.80M	USD	Annual
Payments for acquisitions, net of cash acquired	`PaymentsToAcquireBusinessesNetOfCashAcquired`	$104.60M	USD	Annual
Proceeds from disposals of facilities and other assets	`ProceedsFromSaleOfProductiveAssets`	$17.60M	USD	Annual
Proceeds from disposals of facilities and other assets	`ProceedsFromSaleOfProductiveAssets`	$58.50M	USD	Annual
Proceeds from disposals of facilities and other assets	`ProceedsFromSaleOfProductiveAssets`	$6.00M	USD	Annual
Sale (purchase) of equity investments	`PaymentsForProceedsFromEquityMethodInvestments`	$15.20M	USD	Annual
Sale (purchase) of equity investments	`PaymentsForProceedsFromEquityMethodInvestments`	$-5.40M	USD	Annual
Sale (purchase) of equity investments	`PaymentsForProceedsFromEquityMethodInvestments`	-	USD	Annual
Other investing activities	`PaymentsForProceedsFromOtherInvestingActivities`	$-600.00K	USD	Annual
Other investing activities	`PaymentsForProceedsFromOtherInvestingActivities`	$200.00K	USD	Annual
Other investing activities	`PaymentsForProceedsFromOtherInvestingActivities`	$-300.00K	USD	Annual
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-85.20M	USD	Annual
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-331.70M	USD	Annual
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-88.40M	USD	Annual
Principal payments on long-term debt	`RepaymentsOfLongTermDebt`	$216.30M	USD	Annual
Principal payments on long-term debt	`RepaymentsOfLongTermDebt`	$490.80M	USD	Annual
Principal payments on long-term debt	`RepaymentsOfLongTermDebt`	$343.20M	USD	Annual
Borrowings of long-term debt	`ProceedsFromIssuanceOfLongTermDebt`	$429.40M	USD	Annual
Borrowings of long-term debt	`ProceedsFromIssuanceOfLongTermDebt`	$506.90M	USD	Annual
Borrowings of long-term debt	`ProceedsFromIssuanceOfLongTermDebt`	$299.40M	USD	Annual
Payments of debt issuance costs	`PaymentsOfDebtIssuanceCosts`	$11.70M	USD	Annual
Payments of debt issuance costs	`PaymentsOfDebtIssuanceCosts`	$8.90M	USD	Annual
Payments of debt issuance costs	`PaymentsOfDebtIssuanceCosts`	$8.50M	USD	Annual
Proceeds from equity offerings	`ProceedsFromIssuanceOfCommonStock`	-	USD	Annual
Proceeds from equity offerings	`ProceedsFromIssuanceOfCommonStock`	-	USD	Annual
Proceeds from equity offerings	`ProceedsFromIssuanceOfCommonStock`	$581.80M	USD	Annual
Payments of equity offering costs	`PaymentsOfStockIssuanceCosts`	-	USD	Annual
Payments of equity offering costs	`PaymentsOfStockIssuanceCosts`	-	USD	Annual
Payments of equity offering costs	`PaymentsOfStockIssuanceCosts`	$27.60M	USD	Annual
Payment of premium on debt extinguishment	`DebtInstrumentPrepaymentPenaltyAmount`	$17.80M	USD	Annual
Payment of premium on debt extinguishment	`DebtInstrumentPrepaymentPenaltyAmount`	-	USD	Annual
Payment of premium on debt extinguishment	`DebtInstrumentPrepaymentPenaltyAmount`	-	USD	Annual
Distributions to non-controlling interest holders	`PaymentsOfDividendsMinorityInterest`	$121.20M	USD	Annual
Distributions to non-controlling interest holders	`PaymentsOfDividendsMinorityInterest`	$131.00M	USD	Annual
Distributions to non-controlling interest holders	`PaymentsOfDividendsMinorityInterest`	$109.60M	USD	Annual
Payments related to ownership transactions with non-controlling interest holders	`PaymentsToMinorityShareholders`	$3.20M	USD	Annual
Payments related to ownership transactions with non-controlling interest holders	`PaymentsToMinorityShareholders`	$28.40M	USD	Annual
Payments related to ownership transactions with non-controlling interest holders	`PaymentsToMinorityShareholders`	$27.40M	USD	Annual
Payments of preferred dividends	`PaymentsOfDividendsPreferredStockAndPreferenceStock`	-	USD	Annual
Payments of preferred dividends	`PaymentsOfDividendsPreferredStockAndPreferenceStock`	-	USD	Annual
Payments of preferred dividends	`PaymentsOfDividendsPreferredStockAndPreferenceStock`	$5.10M	USD	Annual
Other financing activities	`ProceedsFromPaymentsForOtherFinancingActivities`	$-900.00K	USD	Annual
Other financing activities	`ProceedsFromPaymentsForOtherFinancingActivities`	$-900.00K	USD	Annual
Other financing activities	`ProceedsFromPaymentsForOtherFinancingActivities`	$-17.90M	USD	Annual
Net cash provided by (used in) financing activities	`NetCashProvidedByUsedInFinancingActivities`	$316.30M	USD	Annual
Net cash provided by (used in) financing activities	`NetCashProvidedByUsedInFinancingActivities`	$-135.90M	USD	Annual
Net cash provided by (used in) financing activities	`NetCashProvidedByUsedInFinancingActivities`	$66.70M	USD	Annual
Net increase (decrease) in cash, cash equivalents and restricted cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$71.70M	USD	Annual
Net increase (decrease) in cash, cash equivalents and restricted cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$-91.60M	USD	Annual
Net increase (decrease) in cash, cash equivalents and restricted cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$225.20M	USD	Annual
Cash, cash equivalents and restricted cash at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$184.60M	USD	Point-in-time
Cash, cash equivalents and restricted cash at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$389.90M	USD	Point-in-time
Cash, cash equivalents and restricted cash at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$93.00M	USD	Point-in-time
Cash, cash equivalents and restricted cash at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$318.20M	USD	Point-in-time
Cash, cash equivalents and restricted cash at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$184.60M	USD	Point-in-time
Cash, cash equivalents and restricted cash at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$389.90M	USD	Point-in-time
Cash, cash equivalents and restricted cash at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$93.00M	USD	Point-in-time
Cash, cash equivalents and restricted cash at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$318.20M	USD	Point-in-time
Interest paid, net of interest income received	`InterestPaidNet`	$203.60M	USD	Annual
Interest paid, net of interest income received	`InterestPaidNet`	$180.30M	USD	Annual
Interest paid, net of interest income received	`InterestPaidNet`	$194.30M	USD	Annual
Cash paid for income taxes	`IncomeTaxesPaidNet`	$1.60M	USD	Annual
Cash paid for income taxes	`IncomeTaxesPaidNet`	$1.50M	USD	Annual
Cash paid for income taxes	`IncomeTaxesPaidNet`	$1.70M	USD	Annual
Non-cash purchases of property and equipment	`NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1`	$30.70M	USD	Annual
Non-cash purchases of property and equipment	`NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1`	$27.70M	USD	Annual
Non-cash purchases of property and equipment	`NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1`	$22.30M	USD	Annual

Stockholders Equity 34 line items

Line Item	Tag	Value	Unit	Period
Beginning Balance, stockholders' equity (shares)	`CommonStockSharesOutstanding`	50.46M	shares	Point-in-time
Beginning Balance, stockholders' equity (shares)	`CommonStockSharesOutstanding`	89.33M	shares	Point-in-time
Beginning Balance, stockholders' equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$882.10M	USD	Point-in-time
Beginning Balance, stockholders' equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$983.40M	USD	Point-in-time
Beginning Balance, stockholders' equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$1.97B	USD	Point-in-time
Beginning Balance, stockholders' equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$1.10B	USD	Point-in-time
Net (loss) income	`NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest`	$6.00M	USD	Annual
Net (loss) income	`NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest`	$21.80M	USD	Annual
Net (loss) income	`NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest`	$-30.40M	USD	Annual
Equity-based compensation	`StockIssuedDuringPeriodValueShareBasedCompensation`	$12.40M	USD	Annual
Equity-based compensation	`StockIssuedDuringPeriodValueShareBasedCompensation`	$9.00M	USD	Annual
Equity-based compensation	`StockIssuedDuringPeriodValueShareBasedCompensation`	$9.20M	USD	Annual
Preferred dividends	`AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings`	$10.30M	USD	Annual
Preferred dividends	`AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings`	$39.50M	USD	Annual
Preferred dividends	`AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings`	$35.70M	USD	Annual
Preferred share conversion	`StockIssuedDuringPeriodValueConversionOfConvertibleSecurities`	$439.70M	USD	Annual
Equity offering	`StockIssuedDuringPeriodValueNewIssues`	$554.20M	USD	Annual
Other comprehensive loss	`OtherComprehensiveIncomeLossNetOfTax`	$-28.30M	USD	Annual
Other comprehensive loss	`OtherComprehensiveIncomeLossNetOfTax`	$-10.30M	USD	Annual
Other comprehensive loss	`OtherComprehensiveIncomeLossNetOfTax`	$29.50M	USD	Annual
Acquisition and disposal of shares of non-controlling interests, net	`NonControllingInterestAcquisitionsAndDisposalsOfInterestsHeldByNonControllingInterestHoldersNet`	$8.30M	USD	Annual
Acquisition and disposal of shares of non-controlling interests, net	`NonControllingInterestAcquisitionsAndDisposalsOfInterestsHeldByNonControllingInterestHoldersNet`	$39.80M	USD	Annual
Acquisition and disposal of shares of non-controlling interests, net	`NonControllingInterestAcquisitionsAndDisposalsOfInterestsHeldByNonControllingInterestHoldersNet`	$131.20M	USD	Annual
Distributions to non-controlling interestsnon-redeemable holders	`MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders`	$87.60M	USD	Annual
Distributions to non-controlling interestsnon-redeemable holders	`MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders`	$81.20M	USD	Annual
Distributions to non-controlling interestsnon-redeemable holders	`MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders`	$73.10M	USD	Annual
Other	`StockholdersEquityOther`	$-100.00K	USD	Annual
Other	`StockholdersEquityOther`	$200.00K	USD	Annual
Ending Balance, stockholders' equity (shares)	`CommonStockSharesOutstanding`	50.46M	shares	Point-in-time
Ending Balance, stockholders' equity (shares)	`CommonStockSharesOutstanding`	89.33M	shares	Point-in-time
Ending Balance, stockholders' equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$882.10M	USD	Point-in-time
Ending Balance, stockholders' equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$983.40M	USD	Point-in-time
Ending Balance, stockholders' equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$1.97B	USD	Point-in-time
Ending Balance, stockholders' equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$1.10B	USD	Point-in-time

Comprehensive Income 15 line items

Line Item	Tag	Value	Unit	Period
Net income	`ProfitLoss`	$1.30M	USD	Annual
Net income	`ProfitLoss`	$45.10M	USD	Annual
Net income	`ProfitLoss`	$70.70M	USD	Annual
Derivative activity	`OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax`	$-28.30M	USD	Annual
Derivative activity	`OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax`	$-10.30M	USD	Annual
Derivative activity	`OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax`	$29.50M	USD	Annual
Comprehensive income (loss)	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$16.80M	USD	Annual
Comprehensive income (loss)	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$100.20M	USD	Annual
Comprehensive income (loss)	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$-9.00M	USD	Annual
Less: Comprehensive income attributable to non-controlling interests	`ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest`	$119.90M	USD	Annual
Less: Comprehensive income attributable to non-controlling interests	`ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest`	$117.40M	USD	Annual
Less: Comprehensive income attributable to non-controlling interests	`ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest`	$141.60M	USD	Annual
Comprehensive loss attributable to Surgery Partners, Inc.	`ComprehensiveIncomeNetOfTax`	$-41.40M	USD	Annual
Comprehensive loss attributable to Surgery Partners, Inc.	`ComprehensiveIncomeNetOfTax`	$-126.40M	USD	Annual
Comprehensive loss attributable to Surgery Partners, Inc.	`ComprehensiveIncomeNetOfTax`	$-103.10M	USD	Annual

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.